Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.
Small-colony variants (SCVs) of Staphylococcus aureus are associated with persistent infections and may be selectively enriched during antibiotic therapy. Three pairs of clonally related S. aureus isolates were recovered from patients receiving systemic antibiotic therapy. Each pair consisted of an isolate with a normal phenotype and an isolate with an SCV phenotype. These SCVs were characterized by reduced susceptibility to gentamicin, reduced hemolytic activity, slow growth, and menadione auxotrophy. Sequencing of the genes involved in menadione biosynthesis revealed mutations in menB, the gene encoding naphthoate synthase, in all three strains with the SCV phenotype. The menB mutations were (i) a 9-bp deletion from nucleotides 55 to 63, (ii) a frameshift mutation that resulted in a premature stop codon at position 230, and (iii) a point mutation that caused the amino acid substitution Gly to Val at codon 233. Fluctuation tests showed that growth-compensated mutants arose in the SCV population of one strain, strain OM1b, at a rate of 1.8 x 10(-8) per cell per generation. Sequence analyses of 23 independently isolated growth-compensated mutants of this strain revealed alterations in the menB sequence in every case. These alterations included reversions to the wild-type sequence and intragenic second-site mutations. Each of the growth-compensated mutants showed a restoration of normal growth and a loss of menadione auxotrophy, increased susceptibility to gentamicin, and restored hemolytic activity. These data show that mutations in menB cause the SCV phenotype in these clinical isolates. This is the first report on the genetic basis of menadione-auxotrophic SCVs determined in clinical S. aureus isolates.
Lannergård
Jonas
J
Department of Cell and Molecular Biology, Microbiology Program, The Biomedical Center, Uppsala University, Uppsala, Sweden.
von Eiff
Christof
C
Sander
Gunnar
G
Cordes
Tina
T
Seggewiss
Jochen
J
Peters
Georg
G
Proctor
Richard A
RA
Becker
Karsten
K
Hughes
Diarmaid
D
D001483:Base Sequence; D017931:DNA Primers / Q000235:genetics; D004269:DNA, Bacterial / Q000235:genetics; D005798:Genes, Bacterial; D006801:Humans; D009154:Mutation; D007652:Oxo-Acid-Lyases / Q000235:genetics / Q000378:metabolism; D010641:Phenotype; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification / Q000378:metabolism*; D024483:Vitamin K 3 / Q000378:metabolism*
D017931:DNA Primers; D004269:DNA, Bacterial; D024483:Vitamin K 3; D007652:Oxo-Acid-Lyases; C525127:1,4-dihydroxy-2-naphthoyl-CoA synthase, Staphylococcus aureus
Antimicrob Agents Chemother. 2008 Jun;52(6):2183-9
18378706
J Bacteriol. 1979 Oct;140(1):92-8
500558
J Infect Dis. 1996 Mar;173(3):739-42
8627043
J Infect Dis. 2003 May 15;187(10):1654-61
12721946
J Bacteriol. 2003 Dec;185(23):6928-37
14617657
J Bacteriol. 2006 Nov;188(22):7765-77
16980462
Nat Rev Microbiol. 2006 Apr;4(4):295-305
16541137
Curr Biol. 2001 Nov 13;11(22):1810-4
11719226
Clin Infect Dis. 1997 Nov;25(5):1250-1
9402396
J Bacteriol. 2006 Jan;188(2):687-93
16385058
Antimicrob Agents Chemother. 1991 Feb;35(2):345-50
1827242
Acc Chem Res. 2001 Feb;34(2):145-57
11263873
Nature. 2006 Mar 16;440(7082):303-7
16541065
Infect Immun. 1980 Feb;27(2):444-8
6991416
J Bacteriol. 1997 Aug;179(15):4706-12
9244256
Clin Infect Dis. 1998 Sep;27(3):419-22
9770133
J Bacteriol. 1981 Jan;145(1):479-88
6257640
Microb Drug Resist. 2002 Winter;8(4):253-60
12523621
J Clin Microbiol. 2004 Mar;42(3):1277-9
15004093
Acta Crystallogr D Biol Crystallogr. 2005 Sep;61(Pt 9):1199-206
16131752
Int J Antimicrob Agents. 2008 Jun;31(6):507-10
18180148
Genetics. 1943 Nov;28(6):491-511
17247100
J Bacteriol. 2008 Feb;190(3):834-42
17905979
Int J Med Microbiol. 2003 Dec;293(6):427-35
14760974
Antimicrob Agents Chemother. 2007 Dec;51(12):4438-46
17923494
Int J Med Microbiol. 2007 Jul;297(4):217-25
17412637
J Bacteriol. 1999 Jan;181(2):501-7
9882664
J Infect Dis. 1994 Oct;170(4):1033-7
7930701
Infect Immun. 1996 Mar;64(3):1070-4
8641763
Clin Infect Dis. 1995 Jan;20(1):95-102
7727677
Clin Infect Dis. 2001 Jun 1;32(11):1643-7
11340539
Antimicrob Agents Chemother. 2000 Nov;44(11):3229-31
11036061